SCHEMBL31365429

SCHEMBL31365429

CCCCCCC(C)CCCC=P(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.40
CSNK1E P49674 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MMP1 P03956 1/20 0.35
MMP3 P08254 1/20 0.35
EPHX2 P34913 1/20 0.34
PKM P14618 1/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP2C19 P33261 1/20 0.34
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11711810 0.85 EPHX2 (0.41) MEN1KMT2ANPSR1EPHX2PKM
SCHEMBL4934443 0.85 EPHX2 (0.41) MEN1KMT2ANPSR1EPHX2PKM
SCHEMBL8756382 0.85 EPHX2 (0.41) MEN1KMT2ANPSR1EPHX2PKM
SCHEMBL8987951 0.83 MEN1 (0.41) MEN1KMT2ANPSR1EPHX2PKM
SCHEMBL4821584 0.81 MEN1 (0.42) ALDH1A1MEN1KMT2ANPSR1EPHX2
SCHEMBL13262112 0.74 CSNK1E (0.39) CSNK1EALDH1A1MEN1KMT2ANPSR1
SCHEMBL808497 0.73 MEN1 (0.41) ALDH1A1MEN1KMT2ANPSR1PKM
SCHEMBL17144326 0.72 CSNK1E (0.43) ACE2CSNK1EALDH1A1MEN1KMT2A
SCHEMBL3322171 0.71 KCNH2 (0.53) ACE2CSNK1EALDH1A1TP53CYP3A4
SCHEMBL31490485 0.71 CSNK1E (0.49) ACE2CSNK1EMEN1KMT2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240409480-A1 HALOALKYL ALKOXYMETHYL ETHER COMPOUND, AND PROCESS FOR PREPARING 4,6,8,10,16-PENTAMETHYLDOCOSANE THEREFROM AND FOR PREPARING SYNTHETIC INTERMEDIATE THEREFOR SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-12-12 US disclosed
CN-119059889-A Haloalkylalkoxymethyl ether compound, process for producing 4,6,8,10,16-pentamethylbehene therefrom, and process for producing synthetic intermediate thereof 信越化学工业株式会社 2024-12-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240409480-A1 HALOALKYL ALKOXYMETHYL ETHER COMPOUND, AND PROCESS FOR PREPARING 4,6,8,10,16-PENTAMETHYLDOCOSANE THEREFROM AND FOR PREPARING SYNTHETIC INTERMEDIATE THEREFOR WEE1, CYP51A1, CYP4Z1 ACE2 797/4885CSNK1E 607/4885ALDH1A1 502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.